On September 23, Guotai Junan International (01788) saw a notable decline in its stock price, closing at HK$5.10 before trading dropped to HK$4.79, reflecting a decrease of over 6% during early trading hours. This price fluctuation drew attention as the company recently disclosed its financial results for the first half of 2025.
In its interim report, Guotai Junan International revealed a significant increase in revenue, reaching HK$2.825 billion, alongside a net profit of HK$550 million. The breakdown of revenue highlighted a rise in commission and fee income to HK$541 million, with interest income amounting to HK$1.196 billion. Additionally, net trading and investment gains reached HK$1.088 billion. The firm also declared an interim dividend of HK$0.05 per share, marking a notable payout ratio of approximately 87%.
However, the company’s performance comes amid evolving regulatory frameworks impacting Chinese brokerage firms. Recently, market speculation indicated that the China Securities Regulatory Commission (CSRC) has advised mainland brokerages to temporarily halt their Real-World Asset (RWA) tokenization initiatives in Hong Kong. Reports suggest that at least two major brokerages received informal directives to refrain from expanding such businesses overseas as part of a strategy to enhance risk management in their operations. This regulatory shift has ignited discussions regarding the future of innovation among brokerages in the international arena.
From a technical analysis perspective, Guotai Junan’s share price showed concerning signals. The moving average indicators highlighted that the 10-day moving average has fallen below the 30-day moving average, forming a “death cross,” typically perceived as a sign of weakening short-term trends. Despite this, the BIAS24 indicator suggests that the stock may be oversold, indicating that there could be potential for a technical rebound as prices deviate significantly from the average cost.
Market participants continue to watch closely as developments unfold, particularly in relation to regulatory influences and the company’s stock performance at these critical technical junctures. As always, while the information presented aims to assist investors, it does not constitute formal investment advice and should be considered within the broader context of market conditions and individual risk assessments.
